Live Breaking News & Updates on அறிவியல் ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ்

Stay updated with breaking news from அறிவியல் ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

First 50,000 doses of QazVak vaccine produced in Kazakhstan


First 50,000 doses of QazVak vaccine produced in Kazakhstan
AKIPRESS.COM - Kazakhstan will begin to administer its homegrown coronavirus vaccine to residents next week, primeminister.kz reported. 
The first 50,000 doses of the QazVak vaccine were produced by the Scientific Research Institute for Biological Safety Problems in Kazakhstan s southern Jambyl province, Anadolu reports citing the statement.
Kazakhstan became one of the top five countries in the world that developed its own vaccine against the pandemic, said Deputy Prime Minister Yerali Tugjanov.
The vaccine was included in the record of the World Health Organization, Tugjanov said, who added that the complete safety of the vaccine has been proven. The biggest advantage of the inactivated vaccine is that it does not cause vaccine-related diseases. ....

Turkey General , Yerali Tugjanov , World Health Organization , Scientific Research Institute For Biological Safety Problems , Scientific Research Institute , Biological Safety Problems , Deputy Prime Minister Yerali , Central Asia , News Agency , வான்கோழி ஜநரல் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , அறிவியல் ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , அறிவியல் ஆராய்ச்சி நிறுவனம் , உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் ,

Kazakhstan's Covid-19 vaccine to be bottled in Turkey


Kazakhstan s Covid-19 vaccine to be bottled in Turkey
500,000 doses of QazVac jabs developed by Kazakhstan against coronavirus to be bottled, packaged in Turkish factory
PHOTO: REUTERS
Bottling and packaging of Kazakhstan s homegrown coronavirus vaccine will be carried out in a factory in Turkey, Kazakh official said on Friday.
Deputy Prime Minister Yerali Tugjanov told reporters the decision on the QazVac vaccine was made because the construction of the production plant has not yet been finalized in Kazakhstan.
He said that controls of the vaccine s 50% compliance with international standards will be completed on April 21.
Then, all clinical trials will be evaluated by the Health Ministry and the final report will be published, he said. ....

Yerali Tugjanov , Health Ministry , Scientific Research Institute For Biological Safety Problems , Prime Minister Yerali Tugjanov , Scientific Research Institute , Biological Safety Problems , ஆரோக்கியம் அமைச்சகம் , அறிவியல் ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , அறிவியல் ஆராய்ச்சி நிறுவனம் , உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் ,